Gluconolactone: an alternative for the treatment of post-inflammatory hyperpigmentation in sensitive skin

Abstract

Sensitive skin is a condition of cutaneous hyper-reactivity, that is encompassing more and more individuals, making aesthetic professionals more afraid of how to proceed with the therapeutic plan in order not to trigger adverse reactions but also succeed in handling the customer’s complaint. Post-inflammatory hyperpigmentation can be cited (PIH), as a well-repeated complaint and the treatments indicated for this case usually cause skin sensitivity. Faced with this information, gluconolactone is introduced, a recent asset in the market that has been highlighted mainly because it does not cause adverse reactions which could be a potential solution to the above case. Then, the main goal of this research was to analyze the feasibility of gluconolactone use for post-inflammatory hyperpigmentation treatment on sensitive skin, proposing a safer alternative for the aesthetic professionals to work with. It was observed through this study, that gluconolactone is highly compatible and tolerated by skins with a tendency to atopy such as atopic dermatitis and rosacea presenting satisfactory results due to its empowering action of the barrier, besides its efficiency over the PIH, through the cell renewal which is provided by it, obtaining a more uniform and smooth skin. Even though a practical study is important for a better understanding, gluconolactone presents itself viable for treating PIH in sensitive skins.